英文别名:
2,5-bis(4-biphenylyl)-1,3,4-oxadiazole;BBOD;BBD;2,5-dibiphenylyl-1,3,4-oxadiazole;NSC90317;UNII-C3HW3HH4YV;NSC 90317;NSC-90317;2,5_di-(4-Biphenylyl)-1,3,4-oxadiazole;2,5-DI(4-BIPHENYLYL)-1,3,4-OXADIAZOLE;BIS({[1,1'-BIPHENYL]-4-YL})-1,3,4-OXADIAZOLE;CS-0132381;1,3,4-OXADIAZOLE, 2,5-BIS(4-BIPHENYLYL)-;2043-06-3;2,5-bis(4-phenylphenyl)-1,3,4-oxadiazole;C3HW3HH4YV;2,5-di-(4-Biphenylyl)-1,3,4-oxadiazole;SR-01000395170-1;2,5-Di-(4-biphenyl)-1,3,4-oxadiazol;1,3,4-OXADIAZOLE, 2,5-BIS((1,1'-BIPHENYL)-4-YL)-;IVVYVRLKDGGUEL-UHFFFAOYSA-N;EINECS 218-046-7;DTXSID80174374;AS-67947;2,5-bis-(4-biphenyl)-yl-1,3,4-oxadiazole;2,5-Di[1,1'-biphenyl]-4-yl-1,3,4-oxadiazole #;2,5-Bis(4-biphenylyl)oxadiazole;2, 5-bis(4-phenylphenyl)-1, 3, 4-oxadiazole;2,5-Bis((1,1'-biphenyl)-4-yl)-1,3,4-oxadiazole;AKOS001577750;1,3,4-Oxadiazole, 2,5-bis([1,1'-biphenyl]-4-yl)-;NS00046402;SR-01000395170;E79054;2,5-Di([1,1'-biphenyl]-4-yl)-1,3,4-oxadiazole;SCHEMBL522555;2,5-bis([1,1'-biphenyl]-4-yl)-1,3,4-oxadiazole;DTXCID4096865;